Logo image of CCB

COASTAL FINANCIAL CORP/WA (CCB) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CCB - US19046P2092 - Common Stock

114.18 USD
+4.45 (+4.06%)
Last: 1/21/2026, 8:00:03 PM
114.18 USD
0 (0%)
After Hours: 1/21/2026, 8:00:03 PM
Fundamental Rating

4

Overall CCB gets a fundamental rating of 4 out of 10. We evaluated CCB against 383 industry peers in the Banks industry. CCB has a bad profitability rating. Also its financial health evaluation is rather negative. CCB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CCB had positive earnings in the past year.
  • CCB had a positive operating cash flow in the past year.
  • Each year in the past 5 years CCB has been profitable.
  • In the past 5 years CCB always reported a positive cash flow from operatings.
CCB Yearly Net Income VS EBIT VS OCF VS FCFCCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • CCB's Return On Assets of 1.05% is fine compared to the rest of the industry. CCB outperforms 65.01% of its industry peers.
  • The Return On Equity of CCB (10.04%) is better than 63.71% of its industry peers.
Industry RankSector Rank
ROA 1.05%
ROE 10.04%
ROIC N/A
ROA(3y)1.19%
ROA(5y)1.09%
ROE(3y)14.03%
ROE(5y)13.26%
ROIC(3y)N/A
ROIC(5y)N/A
CCB Yearly ROA, ROE, ROICCCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.70%, CCB is doing worse than 86.16% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CCB has declined.
  • CCB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 8.7%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-32.34%
PM growth 5Y-21.59%
GM growth 3YN/A
GM growth 5YN/A
CCB Yearly Profit, Operating, Gross MarginsCCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

3

2. Health

2.1 Basic Checks

  • CCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CCB has more shares outstanding
  • The number of shares outstanding for CCB has been increased compared to 5 years ago.
  • CCB has a better debt/assets ratio than last year.
CCB Yearly Shares OutstandingCCB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CCB Yearly Total Debt VS Total AssetsCCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • CCB has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • CCB has a better Debt to FCF ratio (0.19) than 86.42% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that CCB is not too dependend on debt financing.
  • CCB's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. CCB outperforms 68.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.19
Altman-Z N/A
ROIC/WACCN/A
WACC14.17%
CCB Yearly LT Debt VS Equity VS FCFCCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CCB Yearly Current Assets VS Current LiabilitesCCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

7

3. Growth

3.1 Past

  • CCB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.40%.
  • Measured over the past years, CCB shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.42% on average per year.
  • The Revenue has decreased by -2.15% in the past year.
  • CCB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 63.14% yearly.
EPS 1Y (TTM)6.4%
EPS 3Y15.85%
EPS 5Y24.42%
EPS Q2Q%-9.28%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y75.51%
Revenue growth 5Y63.14%
Sales Q2Q%-4.98%

3.2 Future

  • Based on estimates for the next years, CCB will show a very strong growth in Earnings Per Share. The EPS will grow by 35.83% on average per year.
  • Based on estimates for the next years, CCB will show a quite strong growth in Revenue. The Revenue will grow by 10.27% on average per year.
EPS Next Y1.04%
EPS Next 2Y37.64%
EPS Next 3Y35.83%
EPS Next 5YN/A
Revenue Next Year-6.16%
Revenue Next 2Y4.95%
Revenue Next 3Y10.27%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CCB Yearly Revenue VS EstimatesCCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CCB Yearly EPS VS EstimatesCCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

  • CCB is valuated quite expensively with a Price/Earnings ratio of 36.13.
  • Compared to the rest of the industry, the Price/Earnings ratio of CCB indicates a rather expensive valuation: CCB more expensive than 85.64% of the companies listed in the same industry.
  • CCB is valuated rather expensively when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 18.54, the valuation of CCB can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, CCB is valued a bit more expensive than 77.02% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, CCB is valued a bit cheaper.
Industry RankSector Rank
PE 36.13
Fwd PE 18.54
CCB Price Earnings VS Forward Price EarningsCCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCB indicates a rather cheap valuation: CCB is cheaper than 86.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.93
EV/EBITDA N/A
CCB Per share dataCCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCB does not grow enough to justify the current Price/Earnings ratio.
  • CCB's earnings are expected to grow with 35.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)34.63
PEG (5Y)1.48
EPS Next 2Y37.64%
EPS Next 3Y35.83%

0

5. Dividend

5.1 Amount

  • No dividends for CCB!.
Industry RankSector Rank
Dividend Yield 0%

COASTAL FINANCIAL CORP/WA

NASDAQ:CCB (1/21/2026, 8:00:03 PM)

After market: 114.18 0 (0%)

114.18

+4.45 (+4.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-29
Earnings (Next)01-26
Inst Owners81.88%
Inst Owner Change-0.04%
Ins Owners15.43%
Ins Owner Change-3.92%
Market Cap1.73B
Revenue(TTM)548.58M
Net Income(TTM)47.72M
Analysts84.44
Price Target136.88 (19.88%)
Short Float %11.55%
Short Ratio13.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.41%
Min EPS beat(2)-15.86%
Max EPS beat(2)-0.97%
EPS beat(4)1
Avg EPS beat(4)-10.51%
Min EPS beat(4)-26.09%
Max EPS beat(4)0.89%
EPS beat(8)3
Avg EPS beat(8)-10.29%
EPS beat(12)5
Avg EPS beat(12)-7.6%
EPS beat(16)9
Avg EPS beat(16)-2.24%
Revenue beat(2)1
Avg Revenue beat(2)-9.76%
Min Revenue beat(2)-21.87%
Max Revenue beat(2)2.35%
Revenue beat(4)1
Avg Revenue beat(4)-9.98%
Min Revenue beat(4)-21.87%
Max Revenue beat(4)2.35%
Revenue beat(8)3
Avg Revenue beat(8)-1.3%
Revenue beat(12)5
Avg Revenue beat(12)-1.53%
Revenue beat(16)9
Avg Revenue beat(16)6.37%
PT rev (1m)2.29%
PT rev (3m)8.93%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)-10.53%
EPS NY rev (1m)0.06%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 36.13
Fwd PE 18.54
P/S 3.15
P/FCF 6.93
P/OCF 6.67
P/B 3.63
P/tB 3.63
EV/EBITDA N/A
EPS(TTM)3.16
EY2.77%
EPS(NY)6.16
Fwd EY5.39%
FCF(TTM)16.48
FCFY14.43%
OCF(TTM)17.11
OCFY14.99%
SpS36.28
BVpS31.43
TBVpS31.43
PEG (NY)34.63
PEG (5Y)1.48
Graham Number47.28
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 10.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 8.7%
GM N/A
FCFM 45.43%
ROA(3y)1.19%
ROA(5y)1.09%
ROE(3y)14.03%
ROE(5y)13.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-32.34%
PM growth 5Y-21.59%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.19
Debt/EBITDA N/A
Cap/Depr 152.54%
Cap/Sales 1.74%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 522.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC14.17%
ROIC/WACCN/A
Cap/Depr(3y)214.22%
Cap/Depr(5y)240.08%
Cap/Sales(3y)1.36%
Cap/Sales(5y)2.94%
Profit Quality(3y)375.52%
Profit Quality(5y)263.99%
High Growth Momentum
Growth
EPS 1Y (TTM)6.4%
EPS 3Y15.85%
EPS 5Y24.42%
EPS Q2Q%-9.28%
EPS Next Y1.04%
EPS Next 2Y37.64%
EPS Next 3Y35.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y75.51%
Revenue growth 5Y63.14%
Sales Q2Q%-4.98%
Revenue Next Year-6.16%
Revenue Next 2Y4.95%
Revenue Next 3Y10.27%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.04%
FCF growth 3Y109.29%
FCF growth 5Y82.16%
OCF growth 1Y51.04%
OCF growth 3Y105.7%
OCF growth 5Y80.21%

COASTAL FINANCIAL CORP/WA / CCB FAQ

What is the fundamental rating for CCB stock?

ChartMill assigns a fundamental rating of 4 / 10 to CCB.


What is the valuation status of COASTAL FINANCIAL CORP/WA (CCB) stock?

ChartMill assigns a valuation rating of 3 / 10 to COASTAL FINANCIAL CORP/WA (CCB). This can be considered as Overvalued.


Can you provide the profitability details for COASTAL FINANCIAL CORP/WA?

COASTAL FINANCIAL CORP/WA (CCB) has a profitability rating of 3 / 10.


What is the financial health of COASTAL FINANCIAL CORP/WA (CCB) stock?

The financial health rating of COASTAL FINANCIAL CORP/WA (CCB) is 3 / 10.